We did not find any significant differences between CD39+ T cells from healthy individuals and IBD patients, either for the frequency of PD-1+ or HLA-DR/CD38 double-positive T cells (Figure 3A). The gene discussed is ENTPD1; the disease is inflammatory bowel disease.